Free Trial

NKGen Biotech (NKGN) SEC Filings & 10K Form

→ His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad)
Free NKGN Stock Alerts
$1.61
-0.37 (-18.69%)
(As of 04/26/2024 08:53 PM ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media

Recent NKGen Biotech SEC Filings

Export to Excel
DateFilerForm TypeView
04/16/2024
2:07 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/11/2024
7:05 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
3:55 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
4:02 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:11 PM		Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:14 PM		Gagnon Pierre (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:16 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:19 PM		Kim Yong Man (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:20 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
12:05 PM		METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SC 13G
02/14/2024
5:28 AM		NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Radcliffe Capital Management, L.P. (Filed by)
Form SC 13G/A
02/12/2024
8:25 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
4:07 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:31 AM		ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SC 13G/A
01/22/2024
5:12 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
6:50 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:19 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:14 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
12:41 PM		NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
NKMAX Co., Ltd. (Filed by)
Form SC 13D/A
12/15/2023
8:02 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
NKMAX Co., Ltd. (Reporting)
Park Sangwoo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:44 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1/A
12/07/2023
4:23 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
2:50 PM		Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
2:51 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
4:30 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1/A
11/22/2023
4:53 PM		NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:55 PM		Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:36 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:39 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2023
7:05 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2023
7:05 AM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
4:23 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K/A
10/19/2023
4:27 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/10/2023
4:01 PM		NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
NKMAX Co., Ltd. (Filed by)
Form SC 13D
10/10/2023
3:15 PM		Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/05/2023
4:12 PM		NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
5:10 AM		Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
4:24 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
3:16 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form CERT
09/29/2023
2:11 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
11:03 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-A12B
His win rate puts Warren Buffett to shame… (Ad)

Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.

Click here now for the full story.
09/22/2023
3:08 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 424B3
09/22/2023
11:55 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
11:55 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/22/2023
8:26 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
8:27 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/21/2023
6:31 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 424B3
09/19/2023
2:51 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
2:52 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/18/2023
8:25 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
8:26 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/14/2023
8:30 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
8:31 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
09/11/2023
10:30 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
10:30 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
08/30/2023
6:30 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
6:30 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
08/24/2023
7:15 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
08/15/2023
3:30 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2023
3:31 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
08/14/2023
11:15 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form EFFECT
08/10/2023
1:09 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form S-4/A
08/09/2023
1:05 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
07/26/2023
10:54 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2023
10:55 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
07/17/2023
7:00 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
7:00 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
07/17/2023
5:01 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form S-4/A
07/06/2023
11:34 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
06/27/2023
12:37 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
06/26/2023
4:02 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form S-4/A
06/05/2023
7:30 AM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:32 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
05/31/2023
8:45 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
8:46 PM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
05/23/2023
9:29 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Radcliffe Capital Management, L.P. (Filed by)
Form SC 13G
05/22/2023
8:03 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2023
5:01 AM		Graf Acquisition Corp. IV (Subject)
NKGen Biotech (Subject)
Graf Acquisition Corp. IV (Subject)
Form 425
05/15/2023
2:02 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form S-4
Registration statement under Securities Act of 1933  
05/03/2023
3:40 PM		Graf Acquisition Corp. IV (Filer)
NKGen Biotech (Filer)
Graf Acquisition Corp. IV (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NYSE:NKGN) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
His win rate puts Warren Buffett to shame…
Investing Daily
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Has Jeff Bezos Found the Next Nvidia?
InvestorPlace